Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10012817HBVENSG00000175445.17protein_codingLPLNoNo4023A0A1B1RVA9
P06858
TVIS30009488HIVENSG00000175445.17protein_codingLPLNoNo4023A0A1B1RVA9
P06858
TVIS20062755HPVENSG00000175445.17protein_codingLPLNoNo4023A0A1B1RVA9
P06858
TVIS20062584HPVENSG00000175445.17protein_codingLPLNoNo4023A0A1B1RVA9
P06858
TVIS20023685HPVENSG00000175445.17protein_codingLPLNoNo4023A0A1B1RVA9
P06858
TVIS20062644HPVENSG00000175445.17protein_codingLPLNoNo4023A0A1B1RVA9
P06858
TVIS44039988HTLV-1ENSG00000175445.17protein_codingLPLNoNo4023A0A1B1RVA9
P06858
TVIS44039792HTLV-1ENSG00000175445.17protein_codingLPLNoNo4023A0A1B1RVA9
P06858
TCGA Plot Options
Drug Information
GeneLPL
DrugBank IDDB13751
Drug NameGlycyrrhizic acid
Target IDBE0000239
UniProt IDP06858
Regulation Typeinducer
PubMed IDs23678825
CitationsMing LJ, Yin AC: Therapeutic effects of glycyrrhizic acid. Nat Prod Commun. 2013 Mar;8(3):415-8.
GroupsApproved; Experimental
Direct ClassificationTriterpene saponins
SMILES[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
Pathways
PharmGKB
ChEMBLCHEMBL441687